MANENTI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 1.387
NA - Nord America 609
AS - Asia 277
SA - Sud America 15
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.291
Nazione #
GB - Regno Unito 732
US - Stati Uniti d'America 594
CN - Cina 146
SE - Svezia 132
DE - Germania 118
IT - Italia 85
UA - Ucraina 82
FR - Francia 59
IN - India 50
PL - Polonia 36
RU - Federazione Russa 34
TR - Turchia 32
KR - Corea 31
IE - Irlanda 26
NL - Olanda 21
FI - Finlandia 19
EU - Europa 17
BE - Belgio 16
DK - Danimarca 15
CA - Canada 14
CO - Colombia 13
GR - Grecia 9
HK - Hong Kong 8
VN - Vietnam 5
CZ - Repubblica Ceca 2
ID - Indonesia 2
AU - Australia 1
CL - Cile 1
EE - Estonia 1
MA - Marocco 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 2.307
Città #
Southend 699
Chandler 117
Jacksonville 68
Seattle 47
Ann Arbor 46
Ashburn 46
Beijing 37
Warsaw 36
Princeton 35
Wilmington 30
Nanjing 28
Dublin 25
Milan 25
Serra 18
Woodbridge 17
Brussels 16
Mountain View 16
Andover 15
Bengaluru 15
Redmond 15
Sakarya 15
Bogotá 13
Jinan 13
Toronto 13
Boardman 12
Turin 12
Athens 9
Nanchang 9
Shenyang 9
Tianjin 9
Hong Kong 8
Mumbai 8
Somerville 8
Des Moines 7
Auburn Hills 6
Fairfield 6
Los Angeles 6
Dearborn 5
Hefei 5
Washington 5
Berlin 4
Changsha 4
Guangzhou 4
Helsinki 4
Petina 4
Phoenix 4
Scranton 4
Shanghai 4
Grafing 3
Hebei 3
Houston 3
Kunming 3
Lanzhou 3
Redwood City 3
Saint Petersburg 3
Verona 3
Bari 2
Bitonto 2
Bühl 2
Chengdu 2
Haikou 2
Hanover 2
Kiez 2
New York 2
Nuremberg 2
Nürnberg 2
Palaiseau 2
San Diego 2
San Francisco 2
Seoul 2
University Park 2
Zhengzhou 2
Bangalore 1
Beaverton 1
Bologna 1
Boston 1
Boulder 1
Eitensheim 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Hanoi 1
Jiaxing 1
Lima 1
Ningbo 1
North Bergen 1
Norwalk 1
Ottawa 1
Padova 1
Panama City 1
Piscataway 1
Pskov 1
Pune 1
Qingdao 1
Rabat 1
Ringwood 1
Roxbury 1
San Jose 1
Tallinn 1
Voghera 1
Totale 1.645
Nome #
Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years 221
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients 197
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients 190
Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B 178
Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B 167
Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy 166
Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy 164
Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation 161
Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma 158
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine 151
Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma 149
Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis 148
No evidence for ADV resistance in HBeAg negative lamivudine resisstant patients treated with lamivudine-adefovir combination for 3 years 127
No evidence for ADV resistance in HBeAg-negative Lamivudine resistant patients treated with LAMIVUDINE-ADEFOVIR combination for 3 years 124
Low resistance to adefovir combined with lamivudine : a 3-year study of 145 lamivudine-resistant hepatitis B patients 112
Totale 2.413
Categoria #
all - tutte 5.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201945 0 0 0 0 0 0 0 0 0 0 24 21
2019/2020328 46 7 15 29 16 33 30 42 59 28 16 7
2020/2021338 15 25 27 0 24 19 17 38 29 16 97 31
2021/2022266 21 15 13 23 15 10 17 25 28 34 16 49
2022/2023296 38 46 25 48 28 59 3 12 26 0 11 0
2023/2024111 1 11 4 13 34 33 4 5 4 2 0 0
Totale 2.413